ロード中...
hGBP-1 Expression Predicts Shorter Progression-Free Survival in Ovarian Cancers, While Contributing to Paclitaxel Resistance
Ovarian cancer is the gynecological cancer with the poorest prognosis. One significant reason is the development of resistance to the chemotherapeutic drugs used in its treatment. The large GTPase, hGBP-1, has been implicated in paclitaxel resistance in ovarian cell lines. Forced expression of hGBP-...
保存先:
| 出版年: | J Cancer Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5226657/ https://ncbi.nlm.nih.gov/pubmed/28090373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4236/jct.2016.713097 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|